310 related articles for article (PubMed ID: 9521062)
21. Underproduction of interleukin-12 in susceptible mice during progressive leishmaniasis is due to decreased CD40 activity.
Heinzel FP; Rerko RM; Hujer AM
Cell Immunol; 1998 Mar; 184(2):129-42. PubMed ID: 9630839
[TBL] [Abstract][Full Text] [Related]
22. T cells from Leishmania major-susceptible BALB/c mice have a defect in efficiently up-regulating CXCR3 upon activation.
Barbi J; Brombacher F; Satoskar AR
J Immunol; 2008 Oct; 181(7):4613-20. PubMed ID: 18802063
[TBL] [Abstract][Full Text] [Related]
23. The relative contribution of IL-4 receptor signaling and IL-10 to susceptibility to Leishmania major.
Noben-Trauth N; Lira R; Nagase H; Paul WE; Sacks DL
J Immunol; 2003 May; 170(10):5152-8. PubMed ID: 12734362
[TBL] [Abstract][Full Text] [Related]
24. Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity.
Powrie F; Correa-Oliveira R; Mauze S; Coffman RL
J Exp Med; 1994 Feb; 179(2):589-600. PubMed ID: 7905019
[TBL] [Abstract][Full Text] [Related]
25. Deletion of IL-4Ralpha on CD4 T cells renders BALB/c mice resistant to Leishmania major infection.
Radwanska M; Cutler AJ; Hoving JC; Magez S; Holscher C; Bohms A; Arendse B; Kirsch R; Hunig T; Alexander J; Kaye P; Brombacher F
PLoS Pathog; 2007 May; 3(5):e68. PubMed ID: 17500591
[TBL] [Abstract][Full Text] [Related]
26. Coinfection with Listeria monocytogenes potentlxtes the response of BALB/c mice against Leishmania major.
Tabbara KS; Al-Azmi AS; Al Salem JA
J Egypt Soc Parasitol; 2004 Apr; 34(1):349-66. PubMed ID: 15125539
[TBL] [Abstract][Full Text] [Related]
27. IL-12 is required to maintain a Th1 response during Leishmania major infection.
Park AY; Hondowicz BD; Scott P
J Immunol; 2000 Jul; 165(2):896-902. PubMed ID: 10878364
[TBL] [Abstract][Full Text] [Related]
28. CD28 costimulation and parasite dose combine to influence the susceptibility of BALB/c mice to infection with Leishmania major.
Compton HL; Farrell JP
J Immunol; 2002 Feb; 168(3):1302-8. PubMed ID: 11801669
[TBL] [Abstract][Full Text] [Related]
29. The early IL-4 response to Leishmania major and the resulting Th2 cell maturation steering progressive disease in BALB/c mice are subject to the control of regulatory CD4+CD25+ T cells.
Aseffa A; Gumy A; Launois P; MacDonald HR; Louis JA; Tacchini-Cottier F
J Immunol; 2002 Sep; 169(6):3232-41. PubMed ID: 12218142
[TBL] [Abstract][Full Text] [Related]
30. T cell and non-T cell compartments can independently determine resistance to Leishmania major.
Shankar AH; Titus RG
J Exp Med; 1995 Mar; 181(3):845-55. PubMed ID: 7869047
[TBL] [Abstract][Full Text] [Related]
31. Control of Leishmania major infection in BALB/c mice by inhibition of early lymphocyte entry into peripheral lymph nodes.
Laskay T; Wittmann I; Diefenbach A; Röllinghoff M; Solbach W
J Immunol; 1997 Feb; 158(3):1246-53. PubMed ID: 9013966
[TBL] [Abstract][Full Text] [Related]
32. Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells.
Padigel UM; Farrell JP
J Immunol; 2005 May; 174(10):6340-5. PubMed ID: 15879134
[TBL] [Abstract][Full Text] [Related]
33. Vaccination with the Leishmania infantum acidic ribosomal P0 protein plus CpG oligodeoxynucleotides induces protection against cutaneous leishmaniasis in C57BL/6 mice but does not prevent progressive disease in BALB/c mice.
Iborra S; Carrión J; Anderson C; Alonso C; Sacks D; Soto M
Infect Immun; 2005 Sep; 73(9):5842-52. PubMed ID: 16113303
[TBL] [Abstract][Full Text] [Related]
34. Genetic immunization with glycoprotein 63 cDNA results in a helper T cell type 1 immune response and protection in a murine model of leishmaniasis.
Walker PS; Scharton-Kersten T; Rowton ED; Hengge U; Bouloc A; Udey MC; Vogel JC
Hum Gene Ther; 1998 Sep; 9(13):1899-907. PubMed ID: 9741428
[TBL] [Abstract][Full Text] [Related]
35. IL-12Rbeta2-deficient mice of a genetically resistant background are susceptible to Leishmania major infection and develop a parasite-specific Th2 immune response.
Chakir H; Campos-Neto A; Mojibian M; Webb JR
Microbes Infect; 2003 Apr; 5(4):241-9. PubMed ID: 12706437
[TBL] [Abstract][Full Text] [Related]
36. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.
Sadick MD; Heinzel FP; Shigekane VM; Fisher WL; Locksley RM
J Immunol; 1987 Aug; 139(4):1303-9. PubMed ID: 3112230
[TBL] [Abstract][Full Text] [Related]
37. IL-13 is a susceptibility factor for Leishmania major infection.
Matthews DJ; Emson CL; McKenzie GJ; Jolin HE; Blackwell JM; McKenzie AN
J Immunol; 2000 Feb; 164(3):1458-62. PubMed ID: 10640762
[TBL] [Abstract][Full Text] [Related]
38. Characterization of T cell-mediated responses in nonhealing and healing Leishmania major infections in the absence of endogenous IL-4.
Kropf P; Etges R; Schopf L; Chung C; Sypek J; Müller I
J Immunol; 1997 Oct; 159(7):3434-43. PubMed ID: 9317142
[TBL] [Abstract][Full Text] [Related]
39. Recombinant interleukin 12 cures mice infected with Leishmania major.
Heinzel FP; Schoenhaut DS; Rerko RM; Rosser LE; Gately MK
J Exp Med; 1993 May; 177(5):1505-9. PubMed ID: 8097524
[TBL] [Abstract][Full Text] [Related]
40. IL-9 is a susceptibility factor in Leishmania major infection by promoting detrimental Th2/type 2 responses.
Arendse B; Van Snick J; Brombacher F
J Immunol; 2005 Feb; 174(4):2205-11. PubMed ID: 15699153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
